Applied DNA Sciences Inc (APDN)
1.948
+0.07
(+3.92%)
USD |
NASDAQ |
May 22, 16:00
1.85
-0.10
(-5.06%)
After-Hours: 20:00
Applied DNA Sciences Revenue (Annual): 13.37M for Sept. 30, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 13.37M |
| September 30, 2022 | 18.17M |
| September 30, 2021 | 9.028M |
| September 30, 2020 | 1.932M |
| September 30, 2019 | 5.389M |
| September 30, 2018 | 3.903M |
| September 30, 2017 | 4.751M |
| September 30, 2016 | 4.186M |
| September 30, 2015 | 9.008M |
| Date | Value |
|---|---|
| September 30, 2014 | 2.721M |
| September 30, 2013 | 2.036M |
| September 30, 2012 | 1.855M |
| September 30, 2011 | 0.9688M |
| September 30, 2010 | 0.5198M |
| September 30, 2009 | 0.2952M |
| September 30, 2008 | 0.873M |
| September 30, 2007 | 0.1219M |
| September 30, 2006 | 0.0189M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.932M
Minimum
2020
18.17M
Maximum
2022
9.577M
Average
9.028M
Median
2021
Revenue (Annual) Benchmarks
| Fonar Corp | 98.65M |
| XWELL Inc | 30.11M |
| ProPhase Labs Inc | 44.38M |
| Veracyte Inc | 361.05M |
| OncoCyte Corp | 1.503M |